Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
Cooper Companies Inc is a medical instruments & supplies business based in the US. Cooper Companies shares (COO) are listed on the NYSE and all prices are listed in US Dollars. Cooper Companies employs 12,000 staff and has a trailing 12-month revenue of around 0.00.
Our top pick for
Beginners
Our top pick for
Building a portfolio
Our top pick for
Advanced traders
| Latest market close | $313.12 |
|---|---|
| 52-week range | $297.34 - $463.56 |
| 50-day moving average | $347.11 |
| 200-day moving average | $393.41 |
| Wall St. target price | $421.00 |
| PE ratio | 16.9981 |
| Dividend yield | $0.06 (0.02%) |
| Earnings per share (TTM) | $19.03 |
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $313.12 from 2022-06-30
| 1 week (2022-06-24) | -3.21% |
|---|---|
| 1 month (2022-06-01) | -8.77% |
| 3 months (2022-03-31) | -25.02% |
| 6 months (2021-12-31) | -25.26% |
| 1 year (2021-07-01) | -22.30% |
|---|---|
| 2 years (2020-07-01) | 8.91% |
| 3 years (2019-07-01) | 340 |
| 5 years (2017-06-30) | 30.78% |
Valuing Cooper Companies stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Cooper Companies's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Cooper Companies's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 17x. In other words, Cooper Companies shares trade at around 17x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Cooper Companies's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 2.015. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Cooper Companies's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Cooper Companies's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $915.1 million.
The EBITDA is a measure of a Cooper Companies's overall financial performance and is widely used to measure a its profitability.
| Revenue TTM | $3.1 billion |
|---|---|
| Operating margin TTM | 18.58% |
| Gross profit TTM | $2 billion |
| Return on assets TTM | 3.51% |
| Return on equity TTM | 14.39% |
| Profit margin | 30.19% |
| Book value | $142.26 |
| Market capitalisation | $16 billion |
TTM: trailing 12 months
Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like Cooper Companies.
When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.
Total ESG risk: 18.29
Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and Cooper Companies's overall score of 18.29 (as at 12/31/2018) is pretty good – landing it in it in the 24th percentile of companies rated in the same sector.
ESG scores are increasingly used to estimate the level of risk a company like Cooper Companies is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).
Environmental score: 4.6/100
Cooper Companies's environmental score of 4.6 puts it squarely in the 2nd percentile of companies rated in the same sector. This could suggest that Cooper Companies is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.
Social score: 8.68/100
Cooper Companies's social score of 8.68 puts it squarely in the 2nd percentile of companies rated in the same sector. This could suggest that Cooper Companies is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.
Governance score: 5.5/100
Cooper Companies's governance score puts it squarely in the 2nd percentile of companies rated in the same sector. That could suggest that Cooper Companies is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.
Controversy score: 1/5
ESG scores also evaluate any incidences of controversy that a company has been involved in. Cooper Companies scored a 1 out of 5 for controversy – the highest score possible, reflecting that Cooper Companies has managed to keep its nose clean.
Cooper Companies Inc was last rated for ESG on: 2019-01-01.
| Total ESG score | 18.29 |
|---|---|
| Total ESG percentile | 23.8 |
| Environmental score | 4.6 |
| Environmental score percentile | 2 |
| Social score | 8.68 |
| Social score percentile | 2 |
| Governance score | 5.5 |
| Governance score percentile | 2 |
| Level of controversy | 1 |
Dividend payout ratio: 0.46% of net profits
Recently Cooper Companies has paid out, on average, around 0.46% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0.02% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Cooper Companies shareholders could enjoy a 0.02% return on their shares, in the form of dividend payments. In Cooper Companies's case, that would currently equate to about $0.06 per share.
While Cooper Companies's payout ratio might seem low, this can signify that Cooper Companies is investing more in its future growth.
Cooper Companies's most recent dividend payout was on 8 February 2022. The latest dividend was paid out to all shareholders who bought their shares by 19 January 2022 (the "ex-dividend date").
Cooper Companies's shares were split on a 2:1 basis on 24 November 2002. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your Cooper Companies shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for Cooper Companies shares which in turn could have impacted Cooper Companies's share price.
Over the last 12 months, Cooper Companies's shares have ranged in value from as little as $297.34 up to $463.555. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Cooper Companies's is 0.9011. This would suggest that Cooper Companies's shares are less volatile than average (for this exchange).
The Cooper Companies, Inc. , together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, myopia, ocular dryness and eye fatigues in the Americas, Europe, Middle East, Africa, and Asia Pacific. The CooperSurgical segment focuses on family and women's health care, which provides medical devices, fertility, genomics, diagnostics, and contraception to health care professionals and patients worldwide. It offers surgical and office products, including PARAGARD, uterine manipulators, retractors, closure products, point of care products, LEEP products, endosee, and illuminate and fetal pillows; fertility products and services, such as fertility consumables and equipment, and embryo options and preimplantation genetic testing. The Cooper Companies, Inc.
Everything we know about the Intchains Group IPO, plus information on how to buy in.
Everything we know about the Biostage IPO, plus information on how to buy in.
Everything we know about the Wang & Lee Group IPO, plus information on how to buy in.
Everything we know about the OptMed IPO, plus information on how to buy in.
Everything we know about the Lichen China IPO, plus information on how to buy in.
Everything we know about the LeeWay Services IPO, plus information on how to buy in.
Everything we know about the Nano Labs IPO, plus information on how to buy in.
Everything we know about the Warrantee IPO, plus information on how to buy in.
Everything we know about the Treasure Global IPO, plus information on how to buy in.
Everything we know about the BIOLIFE4D IPO, plus information on how to buy in.
